Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Phase 3 Trial Evaluating Adjuvant Transarterial Chemoembolization for TNM Stage I and II Hepatocellular Carcinoma Recurrence After Curative Resection
Conditions
Interventions
Prophylactic Transcatheter Arterial Chemoembolization
Observation
Locations
1
China
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Start Date
March 26, 2014
Primary Completion Date
May 13, 2023
Completion Date
May 13, 2023
Last Updated
May 29, 2024
NCT07485114
NCT06345508
NCT06066138
NCT06811116
NCT04380545
NCT07291076
Lead Sponsor
Zhejiang University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions